Experienced in Pulmonary Edema

Wei T. Gu

99 Shangda Road, 
Shanghai, CN 
Experienced in Pulmonary Edema
99 Shangda Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Wei Gu practices in Shanghai, China. Gu is rated as an Experienced expert by MediFind in the treatment of Pulmonary Edema. Their top areas of expertise are Ventricular Fibrillation, Cerebral Hypoxia, Intrahepatic Cholestasis of Pregnancy, Osteotomy, and Thrombectomy.

Their clinical research consists of co-authoring 597 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Pulmonary Edema.

Locations

99 Shangda Road, Shanghai, 200444, China
Other Locations
180 Si Wang Ting Road, Yangzhou, 225002, China
321 Zhongshan Road, Nanjing, 210008, China
170 Xinsong Road, Minhang, 201199, China
Changle Road 68, Nanjing, 210006, China
No. 68, Changle Road, Nanjing, 210006, China
2600 Donghai Avenue, Bengbu, 233030, China
No.1500 Zhouyuan Road, Pudong, 201318, China
No. 185, Puan Road, Huangpu, 200021, China
2 Anzhen Road, Beijing, China
No.68, Changle Road, Nanjing, 210006, China
Luwan Branch, Shanghai, China
China P.R, Taian, China
88 Jiefang Rd, Hangzhou, 310009, China
500 Dongchan Road, Shanghai, 200241, China
2 Anzhen Road, Beijing, 100029, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including Rearranged in Transfection (RET) Fusion-Positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
A Phase 2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including Rearranged in Transfection (RET) Fusion-Positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 2
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Salbutamol
Study Phase: Phase 3
View 1 Less Clinical Trial

597 Total Publications

SERPINB10 Promotes Neutrophilic Airway Inflammation in Asthma.
SERPINB10 Promotes Neutrophilic Airway Inflammation in Asthma.
Journal: American journal of respiratory cell and molecular biology
Published: October 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Gu's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 76 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile